Medtechs Dig Deep For UK System Positives But Take Issue With MHRA Fees Hike
Delayed GB Regulatory System And NHS Net Zero Roadmap Making Life Tricky
A new UK medtech survey sets out industry’s market access and regulatory concerns and makes clear where system users see the need for improvement. There are some grounds for optimism, but the MHRA’s planned rise in regulatory fees could undo some of the good work.
